Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers in the Sir William Dunn School of Pathology, together with colleagues from across Oxford, have successfully obtained a structure of the surface layer from Gram-negative bacteria, bound to the cell membrane via long sugars called lipopolysaccharide or endotoxin, by applying novel electron tomography techniques.

This proof-of-concept study shows how structural biology is entering a new era, where it is possible to resolve atomic structures directly inside their native environment in cells.

DunnCellpaper2.jpgGram-negative bacteria are widespread, and include several human pathogens, causing antibiotic resistant infections, which are difficult to treat. Most bacteria are surrounded by a protective surface layer made of proteins, termed ‘S-layer’. Due to their copy numbers on prokaryotes (bacteria and archaea), S-layer proteins are the most abundant class of proteins on earth. Despite their abundance and importance, atomic resolution details of S-layers are not available, and S-layers remain an under-explored area of fundamental biology.

This recent study by Tanmay Bharat’s group, in collaboration with Carol Robinson’s group in Department of Chemistry and Phillip Stansfeld’s group in Department of Biochemistry, shows the power of integrated structural biology in resolving atomic structures from cells, and deducing complex biological mechanisms in situ. In addition to the surface layer structure reported, this study reports the native structure and arrangement of endotoxin or lipopolysaccharide, which is a ubiquitous molecule in Gram-negative bacteria, including several human pathogens, as it is found on cells.

This study will have important implications not only in the field of prokaryotic biology related to S-layers, but also in the future of structure-based drug design.

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.